Abstract
Background: To systematically evaluate the effect of green tea on patients with type 2 diabetes. Methods: A computer search Cochrane, PubMed, Embase, CNKI, Wanfang, VIP, and other Chinese and English databases were conducted for randomized controlled trials of green tea in the treatment of patients with type 2 diabetes. The duration of these trials spanned from the establishment of the database to January 10, 2024. The obtained data were subjected to meta-analysis using Stata15.1 software. A total of 15 articles were included, encompassing 722 patients. Results: The meta-analysis results showed that compared to the control group, green tea intervention significantly improved the improvement of fasting blood glucose (SMD = −0.41, 95% CI: −0.67 to −0.19, P = .001), glycated hemoglobin (SMD = −0.68, 95% CI: −1.15 to 0.21, P = .004) and insulin resistance index (SMD = −0.70, 95% CI: −1.18 to −0.22, P = .005) in the experimental group compared to the control group. The differences were statistically significant (P < .05). Conclusion: Green tea significantly improves fasting blood glucose, glycated hemoglobin and insulin resistance in patients with type 2 diabetes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
